AstraZeneca and Sino Biopharmaceutical's subsidiary CTTQ have signed an exclusive licence agreement for TQC3721.
Evogene and Tel Aviv University’s BCDD have partnered to expedite small-molecule drug discovery originating from Israeli academic research.
The FDA is taking action to curb the illicit online trade of unregulated and unapproved ketamine products through a slew of warning letters.
The biotech’s potential launch on the public markets would help fuel development of its clinical-stage, melanocortin-focused pipeline.
The US FDA has granted rare paediatric disease designation to Vanda Pharmaceuticals’ VCA-894A, an investigational antisense oligonucleotide therapy for CMT2S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results